ARTICLE | Distillery Therapeutics
Infectious disease
January 18, 2017 7:07 PM UTC
Cell culture studies suggest CRISPR-Cas9 editing of two or three HIV genes could help prevent reactivation of latent HIV in patients. In an HIV-1-infected human cell line expressing Cas9, lentiviral v...
BCIQ Company Profiles